Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Locatelli

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Nature Neuroscience|February 28, 2012
Primary oligodendrocyte death does not elicit anti-CNS immunityGiuseppe Locatelli, Simone Wörtge, Thorsten Buch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2024
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid TumorsTimothy A Yap, Anthony W Tolcher, Ruth Plummer, et al.
Acta Neuropathologica Communications|March 8, 2023
Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammationDaniela C Ivan, Kristina Carolin Berve, Sabrina Walthert, et al.
British Journal of Cancer|January 29, 2024
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumoursHoward A Burris, Jordan Berlin, Tobias Arkenau, et al.
Nature Neuroscience|August 22, 2018
Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis modelGiuseppe Locatelli, Delphine Theodorou, Arek Kendirli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 8, 2022
CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid CellsKirsten Guse, Nina Hagemann, Lisa Thiele, et al.
Blood|August 15, 2002
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapyMauro Malnati, Francesco Broccolo, Silvia Nozza, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Science Signaling|March 17, 2016
Mouse redox histology using genetically encoded probesYuuta Fujikawa, Leticia P Roma, Mirko C Sobotta, et al.
Multiple Sclerosis and Related Disorders|August 1, 2025
Lost in translation: rethinking animal models of progressive MS (an industry perspective)Florian Von Raison, Paola Zaratin, Martin Stangel, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Nature Neuroscience|February 28, 2012
Primary oligodendrocyte death does not elicit anti-CNS immunityGiuseppe Locatelli, Simone Wörtge, Thorsten Buch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2024
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid TumorsTimothy A Yap, Anthony W Tolcher, Ruth Plummer, et al.
Acta Neuropathologica Communications|March 8, 2023
Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammationDaniela C Ivan, Kristina Carolin Berve, Sabrina Walthert, et al.
British Journal of Cancer|January 29, 2024
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumoursHoward A Burris, Jordan Berlin, Tobias Arkenau, et al.
Nature Neuroscience|August 22, 2018
Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis modelGiuseppe Locatelli, Delphine Theodorou, Arek Kendirli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 8, 2022
CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid CellsKirsten Guse, Nina Hagemann, Lisa Thiele, et al.
Blood|August 15, 2002
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapyMauro Malnati, Francesco Broccolo, Silvia Nozza, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Science Signaling|March 17, 2016
Mouse redox histology using genetically encoded probesYuuta Fujikawa, Leticia P Roma, Mirko C Sobotta, et al.
Multiple Sclerosis and Related Disorders|August 1, 2025
Lost in translation: rethinking animal models of progressive MS (an industry perspective)Florian Von Raison, Paola Zaratin, Martin Stangel, et al.
Pageof 6